Cohance Lifesciences Limited
COHANCE
Rank in Stocks
#6301
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Share Price
$5.14
Market Cap
$1.97B
Change (1 day)
0.22%
Change (1 year)
-56.66%
Country
IN
Trade Cohance Lifesciences Limited (COHANCE)
Category
Healthcare
Operating Margin for Cohance Lifesciences Limited (COHANCE)
Operating Margin as of October 2026 TTM: 48.76%
According to Cohance Lifesciences Limited latest financial reports and stock price the company's current Operating Margin (TTM) is 48.76%. At the end of 2024 the company had an Operating Margin of 43.83%.
Operating Margin history for Cohance Lifesciences Limited from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 48.76% | 96.14% |
| 2025 | 24.86% | -43.28% |
| 2024 | 43.83% | 13.23% |
| 2023 | 38.71% | -7.81% |
| 2022 | 41.99% | 0.38% |
| 2021 | 41.83% | -5.81% |
| 2020 | 44.41% | -58.36% |
| 2019 | 106.64% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -99.53% |
IN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.